These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14402588)

  • 1. Disappearance of factor V activity after incubation of plasm with heparin and heparinoids.
    HOLEMANS R; VERMYLEN C; VERSTRAETE M
    Thromb Diath Haemorrh; 1960 Jun; 4():303-22. PubMed ID: 14402588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombin activity and prolongation of thrombin time; comparative study of heparin and of some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    Arch Int Pharmacodyn Ther; 1955 Jun; 102(1-2):96-104. PubMed ID: 13239250
    [No Abstract]   [Full Text] [Related]  

  • 3. [ANTICOAGULANT DRUG THERAPY IN MYOCARDIAL INFARCT].
    MATSUOKA S; HOMMA T
    Sogo Rinsho; 1964 Mar; 13():463-71. PubMed ID: 14140834
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the interaction between blood platelets and heparinoids].
    HOLEMANS R; DEPREZ A
    Rev Hematol; 1960; 15():192-200. PubMed ID: 14402587
    [No Abstract]   [Full Text] [Related]  

  • 5. [Citrated bovine plasma and anticoagulants in vitro (heparin and heparinoids)].
    QUIVY D
    C R Seances Soc Biol Fil; 1955 Feb; 149(3-4):321-3. PubMed ID: 13240926
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of heparin and heparinoids on experimental thrombosis].
    EYSHOLDT KG
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1954; 277(5):455-70. PubMed ID: 13153149
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental studies on the effect of heparin and heparinoids on fresh thrombi].
    EYSHOLDT KG
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1953; 276():476-8. PubMed ID: 13143836
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticurarimimetic action of heparin and synthetic heparinoids in the rabbit].
    CHEYMOL J; BOURILLET F; LEVASSORT C
    J Physiol (Paris); 1955; 47(1):132-6. PubMed ID: 13243278
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of heparin-heparinoid-mixtures].
    Hörder MH; Stier WD; Brunswig D
    Arzneimittelforschung; 1969 Nov; 19(11):1873-6. PubMed ID: 4190000
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the hemostatic defect caused by anticoagulants by evaluation of the intensity of the hemorrhage. I. Direct anticoagulants (heparin and synthetic heparinoids)].
    FRANDOLI G
    G Gerontol; 1962 Jul; 10():733-43. PubMed ID: 13959207
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanisms of the anticoagulation activity of new semi-synthetic heparinoids].
    Azarova LA; Siatkovskiĭ VA; Kaputskiĭ FN; Torgashov VI
    Gematol Transfuziol; 1991 Apr; 36(4):23-5. PubMed ID: 1712331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On influencing the physiological coagulation time and the clearing factor by total body inunction with alpha-heparin and heparinoid ointments].
    STUETTGEN G; BRUESTER H
    Dermatol Wochenschr; 1960 Jan; 141():97-102. PubMed ID: 13835417
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the fibrinolytic effect of heparin and heparinoids].
    Naegeli T; Matis P
    Zentralbl Chir; 1965 Jun; 90(23):881-3. PubMed ID: 4157844
    [No Abstract]   [Full Text] [Related]  

  • 14. HEPARIN, PROTAMINE AND POLYBRENE. THEIR EFFECT UPON CERTAIN COAGULATION FACTORS AFTER INCUBATION WITH PLASMA.
    BRITTEN A
    Thromb Diath Haemorrh; 1965 Jun; 13():550-60. PubMed ID: 14347876
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.
    Katz BZ; Muhl L; Zwang E; Ilan N; Herishanu Y; Deutsch V; Naparstek E; Vlodavsky I; Preissner KT
    Thromb Haemost; 2007 Dec; 98(6):1193-9. PubMed ID: 18064313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heparinoid and heparin; anticoagulant effects of dexulate, a dextran sulfate preparation].
    ARGE E
    Ugeskr Laeger; 1957 Feb; 119(9):248-51. PubMed ID: 13422709
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thromboblastographic and blood coagulation studies on several synthetic heparinoids].
    DE NICOLA P; ALTIERI S; MAZZETTI GM
    Haematologica; 1956; 41(3):149-84. PubMed ID: 13345162
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect in man of a new heparinoid, treburon.
    FIELD JB; RAMSAY GD; ATTYAH AM; STARR P
    J Lab Clin Med; 1953 Feb; 41(2):208-14. PubMed ID: 13035252
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
    Gatt A; van Veen JJ; Woolley AM; Kitchen S; Cooper P; Makris M
    Thromb Haemost; 2008 Aug; 100(2):350-5. PubMed ID: 18690358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [RESEARCH ON THE FIBRINOLYTIC AND ANTICOAGULANT ACTION OF A SULFURATED DERIVATIVE OF XYLAN (SYNTHETIC HEPARINOID) WITH A LOW-GRADE POLYMERIZATION].
    CIPOLLI PL; GIBELLI A
    Riv Patol Clin; 1963 Aug; 18():395-403. PubMed ID: 14083551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.